LeBauer Cardiovascular Research Foundation — Greensboro, North Carolina

LeBauer Cardiovascular Research Foundation is a clinical research site located in Greensboro, North Carolina, United States 27401.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

LeBauer Cardiovascular Research Foundation has participated in 21 clinical trials with 1 currently active.

Therapeutic areas: Medication Non-adherence, Stent Thrombosis, Heart Failure.

Sponsors: Icahn School of Medicine at Mount Sinai, Carelon Research, Osprey Medical, Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Greensboro

Browse all research sites in North Carolina · View every site in Greensboro

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for LeBauer Cardiovascular Research Foundation?

LeBauer Cardiovascular Research Foundation has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has LeBauer Cardiovascular Research Foundation conducted?

LeBauer Cardiovascular Research Foundation has 21 clinical trials on record, with 1 currently active. Their work covers Medication Non-adherence, Stent Thrombosis, Heart Failure.

Is LeBauer Cardiovascular Research Foundation accredited by Crixeo Clinical Trials?

LeBauer Cardiovascular Research Foundation has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about LeBauer Cardiovascular Research Foundation?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.